Skip to main content
. Author manuscript; available in PMC: 2019 Apr 1.
Published in final edited form as: Am J Transplant. 2017 Nov 1;18(4):843–854. doi: 10.1111/ajt.14523

Figure 7. Allogeneic rat DCD renal transplant model, CD47mAb treatment reduced mitochondrial oxidative stress.

Figure 7

(A) IF staining of PARP and VDAC1 (magnification ×200) showed lower in the CD47mAb-treated group. (B) Western blot and densitometry analysis showed that expression of activated PARP was significantly lower in CD47mAb treated group compared to IgG control group, however, there was no significant difference in VDAC1 expression.